2013
DOI: 10.1016/j.molmet.2013.06.001
|View full text |Cite
|
Sign up to set email alerts
|

Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques

Abstract: Oxidation of LDL (oxLDL) is a crucial step in the development of cardiovascular disease. Treatment with antibodies directed against oxLDL can reduce atherosclerosis in rodent models through unknown mechanisms. We demonstrate that through a novel mechanism of immune complex formation and Fc-γ receptor (FcγR) engagement, antibodies targeting oxLDL (MLDL1278a) are anti-inflammatory on innate immune cells via modulation of Syk, p38 MAPK phosphorylation and NFκB activity. Subsequent administration of MLDL1278a in d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

4
31
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 39 publications
(35 citation statements)
references
References 85 publications
4
31
0
Order By: Relevance
“…Exposure of human PBMCs to anti-MDA-p45 IgG reduced expression of TNF-α and enhanced the secretion of the anti-inflammatory cytokine IL-10. These observations are in line with previous studies by Li et al, 8 demonstrating that anti-MDA-p45 IgG inhibits the release of proinflammatory cytokines. The in vivo relevance of this finding was supported by the observation that treatment of non-human primates with anti-MDA-p45 IgG reduced circulating levels of TNF-α and IL-1β.…”
Section: Discussionsupporting
confidence: 93%
See 2 more Smart Citations
“…Exposure of human PBMCs to anti-MDA-p45 IgG reduced expression of TNF-α and enhanced the secretion of the anti-inflammatory cytokine IL-10. These observations are in line with previous studies by Li et al, 8 demonstrating that anti-MDA-p45 IgG inhibits the release of proinflammatory cytokines. The in vivo relevance of this finding was supported by the observation that treatment of non-human primates with anti-MDA-p45 IgG reduced circulating levels of TNF-α and IL-1β.…”
Section: Discussionsupporting
confidence: 93%
“…7 The mechanism through which anti-p45 IgG inhibits atherosclerosis involves inhibition of inflammation by binding of immune complexes to the inhibitory FcγRII. 8 In accordance, administration of this antibody (MLDL1278a) to diet-induced obese non-human primates resulted in a significant decrease in circulating proinflammatory cytokines. 8 However, treatment with MLDL1278a failed to decrease carotid plaque inflammation, as assessed by positron emission tomography with 18-F-fluorodeoxyglucose, in the randomized, double-blind Goal of Oxidized LDL and Activated Macrophage Inhibition by Exposure to a Recombinant Antibody (GLACIER) study in subjects with stable CVD.…”
mentioning
confidence: 83%
See 1 more Smart Citation
“…27,28 Studies performed on cultured cells have shown that immune complexes of this antibody and oxidized LDL inhibit cytokine release from monocytes through interaction with the inhibitory FcγIIb receptor. 29 Treatment of obese, hypercholesterolemic non-human primates with this antibody resulted in lower plasma levels of pro-inflammatory cytokines. 29 The association between antibodies against oxLDL and CV disease has been extensively studied.…”
Section: Discussionmentioning
confidence: 99%
“…29 Treatment of obese, hypercholesterolemic non-human primates with this antibody resulted in lower plasma levels of pro-inflammatory cytokines. 29 The association between antibodies against oxLDL and CV disease has been extensively studied. Results from studies analyzing antibodies against the intact oxLDL particle have provided inconclusive and partly contradictive results possible due to difficulties in obtained standardized antigens in the detection assays used.…”
Section: Discussionmentioning
confidence: 99%